Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
about
Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Safety profile of lamotrigine in overdoseCurrent and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy.Severe skin complications in patients treated with antidepressants: a literature review.Pharmacogenetics of drug hypersensitivity.Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug.Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.Acute hypersensitivity syndrome caused by valproic Acid: a review of the literature and a case reportThe rational use of potentially hepatotoxic medications in patients with underlying liver disease.Impact of phenytoin therapy on the skin and skin disease.Flare-up reactions in severe drug hypersensitivity: infection or ongoing T-cell hyperresponsivenessHydrochlorothiazide-induced noncardiogenic pulmonary edema: an underrecognized yet serious adverse drug reaction.Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skinCurrent understanding of delayed anticonvulsant hypersensitivity reactions.Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care.Mechanisms of drug-induced allergy.Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.Anticonvulsant hypersensitivity syndrome: an update.HLA and pharmacogenetics of drug hypersensitivity.Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction.Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report.Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series.A case of sulfasalazine-induced hypersensitivity syndrome confirmed by enzyme-linked immunospot assay.[DRESS syndrome. Rare and potentially lethal allergic reaction to carbamazepine - a case report].Lamotrigine induced DRESS syndrome.Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl.First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine.Anticonvulsant hypersensitivity syndrome closely mimicking Kawasaki disease.Type 1 diabetes mellitus in a child with phenobarbital hypersensitivity syndrome.Probable Anticonvulsant Hypersensitivity Syndrome Due to Fosphenytoin in a Pediatric Patient with Streptococcus pneumoniae Meningitis.Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment.Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine.Phenobarbital-induced bullous lesions in a non-comatose patient.Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndromeHypersensitivity reaction associated with phenytoin
P2860
Q26800980-47A60B65-B469-4F77-93B2-40488C103345Q28066916-74BB8DB4-50A6-4C99-9829-CDAF6BB75414Q30277969-4754C48D-81C1-4A08-9319-1348FCBED9DFQ33392937-FF8A937C-4B75-4C49-B7E1-02D0F14292C6Q33955626-60BAC00E-D9BB-41CB-852C-704B894684FCQ34118186-0E188C0D-6485-46C3-9CF6-9FC95DC71E2BQ34301402-F237F933-2528-4932-9681-1C471814D724Q34617803-C3B4372C-4BB9-4BC1-9F3D-BC79FFEF38E5Q35119469-4B05EEC2-B148-4D80-B58C-8CF55B9341D1Q35194515-D02AD95C-B5AA-44B7-93D3-3F276D271981Q35925673-F7194DC4-E141-4C38-A94F-247228D03F8DQ36188341-6A072979-60FC-46C5-AEAA-78D773641DF3Q36257969-E0C9EE14-DD82-427A-AE41-422E2686BA19Q36440366-A805F8AD-FAF4-41D0-827E-00ACCF9F4AD8Q36444480-4E5FA8EB-F641-4DE5-9881-67A0B2DB57BBQ36555922-DF5E83F6-EAA6-42E7-A799-B7C218E68EDDQ36952002-EE23AF30-F0C6-455C-836A-A02496BAF415Q37148433-7B958645-970F-41AE-BD29-EE2E9CA31CDEQ37305421-DC8D29C4-CBD0-466D-9B56-4AE537842CB8Q38026153-97A6C58F-07A0-4C23-93A4-77A99B8F3178Q38037649-D01B250D-DDDB-42DB-B113-9407FE5B8686Q38629821-10AC5DF9-A06C-434F-8A22-A4F29DF760BBQ40148105-CDCD71C4-8EF8-41D4-BFE2-B69CE6FC0C1DQ40217280-2C953267-C7AF-48D1-8689-915B95C53459Q40229782-D08F2B7D-B295-43BE-AF7D-C4762AB83A1BQ40244695-4EF6CAB3-A9E0-402A-9F6D-EA2F571AC02FQ40264063-8C24A50E-B456-43AB-B075-4E70FBD1CC1FQ40289501-379C83D4-12D1-4D98-BC55-4E8B0F5C44E5Q40342657-75EB25BB-55FE-42DE-AE3E-9B4100B7F2ECQ40381081-8097EB07-4F5A-41FE-B3C9-0CDBA7009E38Q40400847-38419BB3-09ED-4F58-8EE4-8DAA807EFC60Q40419320-BD20880A-0D28-420E-8F2E-9EBF3AA81100Q40437969-3D1D58F0-30F6-4FEF-BE7B-AAFCAF3741DFQ40460056-D3605D7D-BB82-4A25-A74A-07B7D490265CQ40473390-8092CD55-5541-44EE-B805-C812B17AA9A1Q40518881-D4A36E6B-97A9-45E8-84AB-490DF8AF1E2BQ41842618-D8CE056B-7207-462F-ABFB-FE21EA117ACEQ41904879-2EB8312A-A56C-4610-9BE3-ABBC588F7516Q42048294-DEED75B3-A4C6-4F5A-A65F-4910F04D08B6Q42250166-9ABCEB0C-2DA3-4738-BE97-758A99219C68
P2860
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@ast
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@en
type
label
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@ast
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@en
prefLabel
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@ast
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@en
P2093
P1433
P1476
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.
@en
P2093
L E Shapiro
S R Knowles
P304
P356
10.2165/00002018-199921060-00005
P577
1999-12-01T00:00:00Z
P6179
1051530960